CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature.
Saved in:
| Title: | CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature. |
|---|---|
| Authors: | Li G; College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, China.; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China., Kang J; Department of Clinical Laboratory, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China., Li X; Department of Blood Transfusion, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China., Zhao L; Department of Pathology, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China., Chen Y; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China., Gong C; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China., Liu Z; College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, China., Zhang B; Department of Blood Transfusion, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jan 26; Vol. 15, pp. 1661650. Date of Electronic Publication: 2026 Jan 26 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41669263 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+G%22">Li G</searchLink>; College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, China.; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Kang+J%22">Kang J</searchLink>; Department of Clinical Laboratory, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Blood Transfusion, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.<br /><searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; Department of Pathology, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Gong+C%22">Gong C</searchLink>; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+B%22">Zhang B</searchLink>; Department of Blood Transfusion, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Jan 26; Vol. 15, pp. 1661650. <i>Date of Electronic Publication: </i>2026 Jan 26 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41669263 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1661650 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1661650 Titles: – TitleFull: CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li G – PersonEntity: Name: NameFull: Kang J – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Zhao L – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Gong C – PersonEntity: Name: NameFull: Liu Z – PersonEntity: Name: NameFull: Zhang B IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 01 Text: 2026 Jan 26 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
